New York

eCapital AR Credit Facility Fuels Growth for N.Y. Pharma Company

eCapital, a leading provider of working capital financing and payments solutions, recently originated a $30 million accounts receivable credit facility for a New York-based manufacturer, packager, and distributor of pharmaceutical and consumer healthcare products.

The company will utilize the facility to diversify its lender group and continue its growth trajectory.

In addition to the working capital, eCapital will also provide the company with comprehensive accounts receivable and customer credit management.

“Over the last year, we have seen quite a different credit environment, and this deal is the perfect example of how, by working with an existing bank partner, we can create an innovative financing solution to help a company grow,” said eCapital Chief Channel Development Officer Miguel Serricchio. “We appreciate the trust that the referral partner and the client have put in eCapital.”

“I was very impressed by the speed and efficiency of both the underwriting and execution processes,” said the company’s Chief Financial Officer. “Each member of the eCapital team was extremely professional and exhibited expertise at their trade. It was an excellent experience, especially considering the current economic climate.”

eCapital offers (and partners on) myriad options, including accounts receivable, inventory, purchase order, and supply chain finance in facility sizes ranging from $250,000 to $200 million. We can help companies of all sizes and stages solve for high growth, challenged credits, tripped covenants, high debtor concentrations, and bankruptcies.

About This Transaction: This transaction was completed by LSQ before its acquisition by eCapital in late 2024. The details reflect the deal as originally announced at that time. Following the acquisition, aspects such as company branding, leadership titles, or organizational structure may have changed.